These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23642988

  • 1. The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study.
    Peh AL, Nieng CH, Ling YH, Kheng TW, Neng TS, Koon OG.
    Asian J Psychiatr; 2013 Jun; 6(3):256-7. PubMed ID: 23642988
    [No Abstract] [Full Text] [Related]

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 3. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 4. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 Sep; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 5. Escitalopram in the treatment of generalized anxiety disorder.
    Baldwin DS, Nair RV.
    Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
    [Abstract] [Full Text] [Related]

  • 6. Managing depressive and anxiety disorders with escitalopram.
    Thase ME.
    Expert Opin Pharmacother; 2006 Mar; 7(4):429-40. PubMed ID: 16503815
    [Abstract] [Full Text] [Related]

  • 7. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [Abstract] [Full Text] [Related]

  • 8. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.
    Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS.
    Pharmacopsychiatry; 2007 Jul; 40(4):152-6. PubMed ID: 17694478
    [Abstract] [Full Text] [Related]

  • 9. Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.
    Cyranowski JM, Frank E, Shear MK, Swartz H, Fagiolini A, Scott J, Kupfer DJ.
    Depress Anxiety; 2005 Jul; 21(3):140-2. PubMed ID: 15965998
    [Abstract] [Full Text] [Related]

  • 10. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S, Osatuke K, Aslam M, Kasckow J.
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [Abstract] [Full Text] [Related]

  • 11. [Escitalopram--second generation of serotonin transporter inhibitors?].
    Rybakowski J, Borkowska AB.
    Psychiatr Pol; 2004 Sep; 38(2):227-39. PubMed ID: 15307289
    [Abstract] [Full Text] [Related]

  • 12. Citalopram-induced major depression in a patient with panic disorder - a case report.
    Hofmann P, Conrad R.
    Psychiatr Danub; 2012 Mar; 24(1):94-6. PubMed ID: 22447093
    [No Abstract] [Full Text] [Related]

  • 13. Escitalopram for psychogenic nausea and vomiting: a report of two cases.
    Hsu WY, Huang SS, Chiu NY.
    J Formos Med Assoc; 2011 Jan; 110(1):62-6. PubMed ID: 21316015
    [Abstract] [Full Text] [Related]

  • 14. Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: a placebo-controlled, crossover study.
    Coryell W, Rickels H.
    J Clin Psychopharmacol; 2009 Apr; 29(2):174-8. PubMed ID: 19512981
    [Abstract] [Full Text] [Related]

  • 15. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 16. Citalopram and panic disorder.
    Bertani A, Perna G, Politi E, Bellodi L.
    Depress Anxiety; 2003 Nov; 4(5):253. PubMed ID: 9167795
    [No Abstract] [Full Text] [Related]

  • 17. Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.
    Lai CH.
    J Clin Psychopharmacol; 2010 Feb; 30(1):88-9. PubMed ID: 20075662
    [No Abstract] [Full Text] [Related]

  • 18. Escitalopram.
    Burke WJ.
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [Abstract] [Full Text] [Related]

  • 19. Milnacipran in panic disorder with agoraphobia and major depressive disorder: a case report.
    Chen MH, Liou YJ.
    Clin Neuropharmacol; 2011 Oct; 34(5):201-2. PubMed ID: 21926486
    [Abstract] [Full Text] [Related]

  • 20. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.
    Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.
    J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.